Skip to main content

With 6.1% CAGR, Bone Graft Substitutes Market Size worth USD 5.71 Billion in 2029

According to Fortune Business Insights, Bone Graft Substitutes Market is expected to reach USD 5.71 billion by 2029, exhibiting a CAGR of 6.1% during the forecast period. Production of Technological Advanced Bone Graft Substitutes to Fuel Industry Growth

Pune, India, May 09, 2022 (GLOBE NEWSWIRE) — The global bone graft substitutes market size was valued at USD 3.33 billion in 2021 and reached USD 3.78 billion in 2022. The market is expected to reach USD 5.71 billion by 2029, exhibiting a CAGR of 6.1% during the forecast period. Several benefits of the substitutes and rising incidences of bone disorders and infections are expected to enhance the industry growth. Fortune Business Insights™ presents this information in its report titled “Bone Graft Substitutes Market, 2022-2029.”

Key Industry Development

  • December 2020- GRAFTYS announced its Quality Management System certification and CE recertification in Europe in conformity with the Medical Device Single Audit Program (MDSAP).

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/bone-graft-substitutes-market-103106


Bone Graft Substitutes Market Report Scope & Segmentation :

Report Coverage Details
Forecast Period 2022 to 2029
Forecast Period 2022 to 2029 CAGR 6.1%
2029 Value Projection USD 5.71 Billion
Base Year 2021
Market Size in 202 USD 3.33 Billion
Historical Data for 2018 to 2020
No. of Pages 150
Segments covered By Application, Type,  End User
Growth Drivers Rising Launch of Synthetic Bone Graft Substitutes to Elevate Industry Growth in North America
Technological Advancements in Substitutes to Propel Market Progress
Companies Announce Novel Products to Expand Market Presence


COVID-19 Impact

Delayed Elective Surgeries to Enhance Industry Progress

The market was negatively affected during the COVID-19 pandemic due to delayed elective surgeries. The rapid spike in COVID-19 patients led to the lack of hospital beds and equipment required for surgeries. Further, declining patient visits are expected to decline the demand for substitutes. However, lockdown relaxations increased the number of hospital visits, thereby enhancing the demand for bone graft substitutes. This factor propelled the market progress during the pandemic.

Segments

Synthetic Segment to Dominate Owing to Rising Product Launches

By type, the market is segmented into allograft, demineralized bone matrix (DBM), synthetic, and xenograft.

The synthetic segment is expected to dominate the market share due to rising product launches. Further, the rising prevalence of bone disorders in the region is expected to enhance the demand for the product. These factors may enhance the segmental growth.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/bone-graft-substitutes-market-103106


Spinal Fusion Segment to Hold Largest Market Share Owing to Extensive Substitutes Adoption

Based on application, the market is classified into spinal fusion, joint reconstruction, foot & ankle, and others.

Spinal fusion is expected to dominate the market share due to extensive adoption of substitutes. Further, rising cases of patients suffering from spine disorders are expected to propel the demand for the product.

Hospital Segment to Grow Positively Owing to Rising Orthopedic Procedures

As per end-user, the market is classified into specialty clinics, hospitals, and others.

The hospitals segment is expected to grow positively due to rising orthopedic procedures. Further, the strong number of orthopedists working from hospitals is expected to enhance the demand for substitutes.

Regionally, it is clubbed into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driving Factors

Technological Advancements in Substitutes to Propel Market Progress

Bone graft substitutes are biologics used as an alternative option for autologous bone grafts. They are used to treat union or non-union surgeries, spinal fusion, and bone defects. Rapid technological advancements in substitutes may enhance the product demand. Further, the rising number of lumbar spine surgeries may elevate the adoption of surgeries. For example, as per the research published by the NCBI in December 2018, the number of lumbar spine fusion surgeries witnessed a rapid incline at a rate of 26 per 100,000 adults. These factors may drive the bone graft substitutes market growth.

However, clinical limitations of the substitutes are likely to hinder the market’s progress.

Speak To Our Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/bone-graft-substitutes-market-103106


Regional Insights

Rising Launch of Synthetic Bone Graft Substitutes to Elevate Industry Growth in North America

North America is expected to dominate the bone graft substitutes market share due to the rising launch of synthetic bone graft substitutes. The market in North America was valued at USD 1.53 billion in 2021 and is expected to gain a huge portion of the global market share. Furthermore, the presence of a huge patient pool suffering from bone disorders is expected to enhance the industry growth.

In Europe, the rising prevalence of bone fractures and spinal disorders is expected to enhance the adoption of the product. Further, rising reimbursement policies and strong research & development are expected to boost the product adoption.

In Asia Pacific, the increasing geriatric population and the rising prevalence of arthritis are expected to enhance the demand for the product. Furthermore, strong investments to expand brand presence may foster the industry growth.

Competitive Landscape

Companies Announce Novel Products to Expand Market Presence

Prominent players operating in the market announce novel products to expand their market presence globally. For example, Isto Biologics launched its Influx Demineralized Bone Matrix (DBM) Putty in September 2019 for the expansion of its Influx portfolio. This development may allow the company to enhance its market presence. Further, companies devise partnerships, acquisitions, mergers, research and development, and expansions to boost their market position globally.

Quick Buy – Bone Graft Substitutes Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/103106


List of Key Players Profiled in the Report

  • Medtronic PLC (Ireland)
  • DePuy Synthes Companies (Johnson & Johnson Services, Inc.) (U.S.)
  • Stryker (U.S.)
  • Zimmer Biomet (U.S.)
  • Smith & Nephew plc (U.K.)
  • SeaSpine (U.S.)
  • AlloSource (U.S.)
  • Bioventus (U.S.)
  • MTF Biologics (U.S.)
  • Orthofix Holdings, Inc. (U.S.)

Table Of Contents :

  • Bone Graft Substitutes Market Introduction
    • Market Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Recent Industry Developments Such as Mergers & Acquisitions
    • Insights on Funding Scenario Pertaining to Research and Development of Bone Grafts Substitutes
    • Industry Background Pertaining to Bone Graft Substitutes
    • New Product Launches
    • Impact of COVID-19 on Bone Graft Substitutes Market
  • Global Bone Graft Substitutes Market Analysis, Insights and Forecast, 2018-2029
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      •  Allograft
      •  Demineralized Bone Matrix (DBM)
      •  Synthetic
        •  Polymers
        •  Ceramic
          •  Hydroxyapatite
          •  Beta TCP
          •  Others
      •  Xenograft
    • Market Analysis, Insights and Forecast – By Application
      •  Spinal Fusion
      •  Joint Reconstruction
      •  Foot & Ankle
      •  Others
    • Market Analysis, Insights and Forecast – By End-user
      •  Hospitals
      •  Specialty Clinics
      •  Others
    • Market Analysis, Insights and Forecast – By Region
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa

Toc Continue..


Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/enquiry/customization/bone-graft-substitutes-market-103106


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Read Press Release:https://www.fortunebusinessinsights.com/press-release/bone-graft-substitutes-market-10055

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.